Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Computer-aided Molecular Design of Compounds Targeting Histone Modifying Enzymes. Local targets link to admitted publications; unresolved targets remain external evidence.
The immune hallmarks of cancer
2011 · External reference
10.1007/s00109-011-0733-7
10.1007/s00109-011-0733-7 · External reference
10.1038/cr.2011.24
10.1038/cr.2011.24 · External reference
10.1016/j.ceb.2007.04.002
10.1016/j.ceb.2007.04.002 · External reference
10.1056/nejmra1112635
10.1056/nejmra1112635 · External reference
Development of DNA methyltransferase inhibitors for the treatment of neoplastic diseases
10.2174/092986709788612738 · 2009 · External reference
10.1016/b978-0-12-380866-0.60002-2
10.1016/b978-0-12-380866-0.60002-2 · External reference
DNA methyltransferase inhibitors for cancer therapy
10.1097/ppo.0b013e31803c7245 · 2007 · External reference
microRNA biogenesis pathway as therapeutic target for human disease and cancer
10.2174/138161213804581846 · 2013 · External reference
Unresolved reference
2010 · External reference
10.1038/nrd4140
10.1038/nrd4140 · External reference
Unresolved reference
2010 · External reference
10.1016/b978-141603703-3.10005-6
10.1016/b978-141603703-3.10005-6 · External reference
10.1016/j.cell.2007.01.029
10.1016/j.cell.2007.01.029 · External reference
10.1016/j.cell.2007.02.005
10.1016/j.cell.2007.02.005 · External reference
10.1038/nbt.1678
10.1038/nbt.1678 · External reference
10.1016/j.drudis.2014.05.005
10.1016/j.drudis.2014.05.005 · External reference
Modulation of epigenetic targets for anticancer therapy: clinicopathological relevance, structural data and drug discovery perspectives
10.2174/138161213804581918 · 2013 · External reference
10.1016/j.tig.2011.06.006
10.1016/j.tig.2011.06.006 · External reference
10.1016/j.cell.2008.10.036
10.1016/j.cell.2008.10.036 · External reference
10.1007/s00726-010-0530-6
10.1007/s00726-010-0530-6 · External reference
10.1002/9783527627073.ch8
10.1002/9783527627073.ch8 · External reference
10.1038/nrc2876
10.1038/nrc2876 · External reference
10.1016/j.ejca.2005.08.010
10.1016/j.ejca.2005.08.010 · External reference
10.1038/cr.2011.22
10.1038/cr.2011.22 · External reference
10.3390/ijms12128661
10.3390/ijms12128661 · External reference
10.1038/onc.2011.601
10.1038/onc.2011.601 · External reference
Targeting epigenetic enzymes for drug discovery
10.1016/j.cbpa.2010.06.174 · 2010 · External reference
Cracking the code: the promise of epigenetics
10.1021/ml300141h · 2012 · External reference
10.1016/j.drudis.2010.10.006
10.1016/j.drudis.2010.10.006 · External reference
10.1016/j.drudis.2009.10.010
10.1016/j.drudis.2009.10.010 · External reference
10.1158/1535-7163.mct-08-0860
10.1158/1535-7163.mct-08-0860 · External reference
10.1016/j.ejca.2009.03.001
10.1016/j.ejca.2009.03.001 · External reference
10.1007/bf02664934
10.1007/bf02664934 · External reference
10.1016/j.ejca.2009.01.003
10.1016/j.ejca.2009.01.003 · External reference
10.1038/nm.2305
10.1038/nm.2305 · External reference
Epigenetic targets of bioactive dietary components for cancer prevention and therapy
10.1007/s13148-010-0011-5 · 2010 · External reference
10.1021/cr900047g
10.1021/cr900047g · External reference
10.1038/hdy.2010.42
10.1038/hdy.2010.42 · External reference
10.1016/j.ddstr.2010.04.002
10.1016/j.ddstr.2010.04.002 · External reference
10.1016/j.biocel.2008.07.024
10.1016/j.biocel.2008.07.024 · External reference
Epigenetics: more than genetics
10.4161/fly.6400 · 2008 · External reference
10.1016/j.biocel.2007.03.011
10.1016/j.biocel.2007.03.011 · External reference
Chromatin control and cancer-drug discovery: realizing the promise
10.1016/s1359-6446(05)03691-3 · 2006 · External reference
10.1016/j.semcdb.2009.10.007
10.1016/j.semcdb.2009.10.007 · External reference
Protein methyltransferases as a target class for drug discovery
10.1038/nrd2974 · 2009 · External reference
Chemical biology of lysine demethylases
10.2174/1875397301005010062 · 2011 · External reference
The future therapeutic potential of histone demethylases: a critical analysis
2009 · External reference
10.1016/j.bmc.2011.01.046
10.1016/j.bmc.2011.01.046 · External reference
SnapShot: histone modifications
10.1016/j.cell.2014.09.037 · 2014 · External reference
10.1126/science.1063127
10.1126/science.1063127 · External reference
10.1038/nature04048
10.1038/nature04048 · External reference
Switching on epigenetic therapy
10.1016/j.cell.2009.11.038 · 2009 · External reference
10.1016/j.drudis.2011.04.007
10.1016/j.drudis.2011.04.007 · External reference
10.1016/j.pharmthera.2013.03.010
10.1016/j.pharmthera.2013.03.010 · External reference
10.1016/j.ddstr.2011.12.001
10.1016/j.ddstr.2011.12.001 · External reference
10.1038/nrd3674
10.1038/nrd3674 · External reference
10.1038/nrg3173
10.1038/nrg3173 · External reference
The NSD1 and EZH2 overgrowth genes, similarities and differences
10.1002/ajmg.c.31359 · 2013 · External reference
Crosstalk among epigenetic pathways regulates neurogenesis
2012 · External reference
10.1038/nature10656
10.1038/nature10656 · External reference
10.1038/ng.154
10.1038/ng.154 · External reference
10.1128/mcb.00285-09
10.1128/mcb.00285-09 · External reference
10.1016/j.sbi.2011.08.004
10.1016/j.sbi.2011.08.004 · External reference
10.1155/2011/371832
10.1155/2011/371832 · External reference
Rejuvenating sirtuins: the rise of a new family of cancer drug targets
10.2174/138161213804581954 · 2013 · External reference
Sorting out functions of sirtuins in cancer
2013 · External reference
10.1016/j.cell.2011.10.054
10.1016/j.cell.2011.10.054 · External reference
10.1038/nature08197
10.1038/nature08197 · External reference
Unresolved reference
2015 · External reference
10.1016/j.freeradbiomed.2012.10.525
10.1016/j.freeradbiomed.2012.10.525 · External reference
10.1038/sj.onc.1210619
10.1038/sj.onc.1210619 · External reference
10.1111/ijcp.12436
10.1111/ijcp.12436 · External reference
Protein methyltransferase inhibitors as personalized cancer therapeutics
10.1016/j.ddstr.2011.08.001 · 2012 · External reference
Small molecules DNA methyltransferases inhibitors
10.1039/c1md00194a · 2011 · External reference
10.1007/s00109-010-0668-4
10.1007/s00109-010-0668-4 · External reference
10.1002/cncr.25482
10.1002/cncr.25482 · External reference
Regulation and Function of DNA and Histone Methylations
10.2174/138161213804581990 · 2013 · External reference
10.2217/fon.10.157
10.2217/fon.10.157 · External reference
Unresolved reference
2011 · External reference
10.1016/s0168-9525(02)02667-7
10.1016/s0168-9525(02)02667-7 · External reference
10.1016/j.cell.2004.12.012
10.1016/j.cell.2004.12.012 · External reference
10.1038/nrm3327
10.1038/nrm3327 · External reference
10.1016/j.molcel.2008.02.014
10.1016/j.molcel.2008.02.014 · External reference
10.1016/j.cell.2009.02.027
10.1016/j.cell.2009.02.027 · External reference
10.1016/j.cell.2007.09.046
10.1016/j.cell.2007.09.046 · External reference
10.1038/nature02926
10.1038/nature02926 · External reference
10.1016/j.tcb.2011.06.001
10.1016/j.tcb.2011.06.001 · External reference
Poly(ADP-ribose) polymerase-1 (PARP-1) inhibitors in cancer chemotherapy
10.2174/157489206775246430 · 2006 · External reference
10.1038/nrd1718
10.1038/nrd1718 · External reference
10.1016/j.biocel.2008.07.023
10.1016/j.biocel.2008.07.023 · External reference
The expanding field of poly(ADP-ribosyl)ation reactions. “Protein modifications: beyond the usual suspects” review series
10.1038/embor.2008.191 · 2008 · External reference
Metal-based inhibition of poly(ADP-ribose) polymerase—the guardian angel of DNA
10.1021/jm2000135 · 2011 · External reference
10.1038/nrc2812
10.1038/nrc2812 · External reference
10.1007/s00726-010-0676-2
10.1007/s00726-010-0676-2 · External reference
10.1016/j.tibs.2009.12.003
10.1016/j.tibs.2009.12.003 · External reference
10.1016/j.chembiol.2010.12.001
10.1016/j.chembiol.2010.12.001 · External reference
Post-translational modifications: bittersweet memories: linking metabolism to epigenetics through O-GlcNAcylation
10.1038/nrm3334 · 2012 · External reference
10.1073/pnas.1009023107
10.1073/pnas.1009023107 · External reference
10.1074/jbc.m111.284885
10.1074/jbc.m111.284885 · External reference
10.1186/1747-1028-6-15
10.1186/1747-1028-6-15 · External reference
Peptidylarginine deiminase 4 and citrullination in health and disease
10.1016/j.autrev.2009.06.002 · 2010 · External reference
10.1111/j.1742-4658.2005.04839.x
10.1111/j.1742-4658.2005.04839.x · External reference
K8 and K12 are biotinylated in human histone H4
10.1111/j.1432-1033.2004.04167.x · 2004 · External reference
Function and metabolism of sirtuin metabolite O-acetyl-ADP-ribose
10.1016/j.bbapap.2010.02.007 · 2010 · External reference
10.1016/j.cell.2007.05.009
10.1016/j.cell.2007.05.009 · External reference
Phosphorylation of histone H3 Thr-45 is linked to apoptosis
10.1074/jbc.m109.005421 · 2009 · External reference
Phosphorylation of basic amino acid residues in proteins: important but easily missed
10.18388/abp.2011_2258 · 2011 · External reference
10.1126/science.1101400
10.1126/science.1101400 · External reference
10.1093/nar/gkq463
10.1093/nar/gkq463 · External reference
10.1128/mmbr.00040-05
10.1128/mmbr.00040-05 · External reference
10.1016/j.jnutbio.2005.03.025
10.1016/j.jnutbio.2005.03.025 · External reference
O-GlcNAcylation, an epigenetic mark
2014 · External reference
Successful applications of computer aided drug discovery: moving drugs from concept to the clinic
10.2174/156802610790232251 · 2010 · External reference
10.1007/s10822-007-9142-y
10.1007/s10822-007-9142-y · External reference
10.1007/s10822-011-9517-y
10.1007/s10822-011-9517-y · External reference
Freely accessible databases of commercial compounds for high-throughput virtual screenings
10.2174/156802612800166710 · 2012 · External reference
CoCoCo: a free suite of multiconformational chemical databases for high-throughput virtual screening purposes
10.1039/c0mb00039f · 2010 · External reference
Use of large multiconformational databases with structure-based pharmacophore models for fast screening of commercial compound collections
10.1186/1758-2946-3-s1-p27 · 2011 · External reference
10.1016/j.ddtec.2010.07.004
10.1016/j.ddtec.2010.07.004 · External reference
10.1039/c1md00199j
10.1039/c1md00199j · External reference
Targeting epigenetics in drug discovery
10.1002/cmdc.201400084 · 2014 · External reference
10.1021/cb500286b
10.1021/cb500286b · External reference
10.1016/j.tibtech.2014.09.002
10.1016/j.tibtech.2014.09.002 · External reference
10.1016/j.mam.2012.06.005
10.1016/j.mam.2012.06.005 · External reference
Epigenetic drug discovery special issue
10.1016/j.bmc.2011.05.053 · 2009 · External reference
10.1016/j.bmc.2011.01.029
10.1016/j.bmc.2011.01.029 · External reference
10.1016/j.drudis.2011.02.003
10.1016/j.drudis.2011.02.003 · External reference
Inhibitors of DNA methyltransferases: insights from computational studies
2012 · External reference
Discovery of a series of small molecules as potent histone deacetylase inhibitors
10.3109/14756366.2013.780237 · 2014 · External reference
10.1039/c3cp53511h
10.1039/c3cp53511h · External reference
Energy based pharmacophore mapping of HDAC inhibitors against class I HDAC enzymes
10.1016/j.bbapap.2012.08.009 · 2013 · External reference
10.1016/j.bmcl.2012.12.067
10.1016/j.bmcl.2012.12.067 · External reference
Docking-enabled pharmacophore model for histone deacetylase 8 inhibitors and its application in anti-cancer drug discovery
10.1016/j.jmgm.2010.07.007 · 2010 · External reference
Computational identification of novel histone deacetylase inhibitors by docking based QSAR
10.1016/j.compbiomed.2012.04.001 · 2012 · External reference
10.1021/ci800366f
10.1021/ci800366f · External reference
3D-QSAR studies of HDACs inhibitors using pharmacophore-based alignment
10.1016/j.ejmech.2008.12.008 · 2009 · External reference
Pharmacophore modeling and virtual screening studies to design some potential histone deacetylase inhibitors as new leads
10.1016/j.jmgm.2007.07.002 · 2008 · External reference
10.1002/cmdc.200900500
10.1002/cmdc.200900500 · External reference
Discovery of inhibitors of Schistosoma mansoni HDAC8 by combining homology modeling
10.1021/ci5004653 · 2014 · External reference
Structure-based identification of drug-like inhibitors of p300 histone acetyltransferase
2013 · External reference
10.1016/j.chembiol.2010.03.006
10.1016/j.chembiol.2010.03.006 · External reference
10.1021/cb4001926
10.1021/cb4001926 · External reference
Expanding the druggable space of the LSD1/CoREST epigenetic target: new potential binding regions for drug-like molecules, peptides, protein partners, and chromatin
10.1371/journal.pcbi.1003158 · 2013 · External reference
Lysine-specific demethylase 1-selective inactivators: protein-targeted drug delivery mechanism
10.1002/anie.201303999 · 2013 · External reference
10.5936/csbj.201402002 · Admitted local publication
Heterogeneous antibody-based activity assay for lysine specific demethylase 1 (LSD1) on a histone peptide substrate
10.1177/1087057114529156 · 2014 · External reference
10.1016/j.jmgm.2014.06.005
10.1016/j.jmgm.2014.06.005 · External reference
10.1002/cmdc.200800104
10.1002/cmdc.200800104 · External reference
10.1021/jm500487d
10.1021/jm500487d · External reference
10.1002/cmdc.200800301
10.1002/cmdc.200800301 · External reference
How the flexibility of human histone deacetylases influences ligand binding: an overview
2015 · External reference
Epigenetic molecular recognition: a biomolecular modeling perspective
10.1002/cmdc.201300510 · 2014 · External reference
Insight into the key interactions of bromodomain inhibitors based on molecular docking, interaction fingerprinting, molecular dynamics and binding free energy calculation
10.1039/c4mb00723a · 2015 · External reference
Inhibition and mechanism of HDAC8 revisited
2014 · External reference
Docking ligands into flexible and solvated macromolecules. 6. Development and application to the docking of HDACs and other zinc metalloenzymes inhibitors
10.1021/ci400550m · 2014 · External reference
Computational exploration of zinc binding groups for HDAC inhibition
10.1021/jo400406g · 2013 · External reference
De novo peptide design and experimental validation of histone methyltransferase inhibitors
10.1371/journal.pone.0090095 · 2014 · External reference
10.1016/j.molmed.2013.08.006
10.1016/j.molmed.2013.08.006 · External reference
Nature or nurture: let food Be your epigenetic medicine in chronic inflammatory disorders
10.1016/j.bcp.2010.07.029 · 2010 · External reference
10.3109/10409238.2011.557713
10.3109/10409238.2011.557713 · External reference
Cancer cell metabolism, epigenetics and the potential influence of dietary components — a perspective
2012 · External reference
10.1021/tx200378c
10.1021/tx200378c · External reference
10.3748/wjg.15.257
10.3748/wjg.15.257 · External reference
